Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Expert Opinion on Pharmacotherapy
|
November 29, 2023
Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
Sarah G Bridgeman, Anna K Martino, Lindsay C Strowd
The Journal of Dermatological Treatment
|
December 16, 2025
Should we be optimistic for the development of new psoriasis therapies?
Anna K Martino, Alice L Mikulinsky, Robin C Yi, et al.
The Journal of Dermatological Treatment
|
November 27, 2024
Assessing secondary adherence to topical treatments: scoping review revealing lack of standardized approach in clinical research
Emily E Balding, Anna K Martino, Katherine R Salisbury, et al.
JAAD International
|
February 2, 2026
Handheld digital microscope for dermatoscopy
Chenan A Huang, Anna K Martino, Emily E Antalika, et al.
Nature Communications
|
April 13, 2023
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
Bhavana Palakurthi, Shaneann R Fross, Ian H Guldner, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Expert Opinion on Pharmacotherapy
|
November 29, 2023
Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
Sarah G Bridgeman, Anna K Martino, Lindsay C Strowd
The Journal of Dermatological Treatment
|
December 16, 2025
Should we be optimistic for the development of new psoriasis therapies?
Anna K Martino, Alice L Mikulinsky, Robin C Yi, et al.
The Journal of Dermatological Treatment
|
November 27, 2024
Assessing secondary adherence to topical treatments: scoping review revealing lack of standardized approach in clinical research
Emily E Balding, Anna K Martino, Katherine R Salisbury, et al.
JAAD International
|
February 2, 2026
Handheld digital microscope for dermatoscopy
Chenan A Huang, Anna K Martino, Emily E Antalika, et al.
Nature Communications
|
April 13, 2023
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
Bhavana Palakurthi, Shaneann R Fross, Ian H Guldner, et al.
Page
of 1